From the Guidelines
Neurodengue, a neurological manifestation of dengue fever, is estimated to occur in a small percentage of dengue cases, although the exact prevalence is not specified in the provided evidence. The provided evidence does not directly address the prevalence of neurodengue, but it discusses the epidemiology and clinical manifestations of dengue and Zika viruses 1.
Key Points
- Dengue and Zika viruses are transmitted by Aedes species mosquitoes, primarily Aedes aegypti, which are present throughout the tropics and subtropics 1.
- Infection with dengue virus can result in an acute illness that includes fever, rash, myalgia, and arthralgia, and certain patients will progress to potentially fatal severe dengue 1.
- The incidence of dengue has doubled each decade since 1990, with an estimated 58 million symptomatic infections and 13,000 deaths worldwide in 2013 1.
Clinical Considerations
- The clinical manifestations of dengue and Zika viruses can include neurological syndromes, such as Guillain-Barré syndrome and other neurologic syndromes 1.
- The management of dengue and Zika virus infections is primarily supportive, including fluid management, antipyretics, and neurological monitoring.
- Prevention focuses on vector control measures and avoiding mosquito bites in endemic regions.
Outcome
- Early recognition and prompt supportive care are crucial in improving outcomes for patients with dengue and Zika virus infections, including those with neurological manifestations 1.
From the Research
Prevalence of Neurodengue
- There are no research papers to assist in answering this question, as the provided studies focus on dengue fever, its treatment options, fluid management in severe dengue, and the rising cases of dengue and chikungunya in the American regions, but do not specifically address the prevalence of neurodengue 2, 3, 4, 5, 6.
- The studies discuss the importance of fluid management in dengue shock syndrome, the use of crystalloids and colloids in treatment, and the need for effective countermeasures to control the spread of vector-borne diseases 3, 4, 5.
- However, none of the studies provide information on the prevalence of neurodengue, which is a specific complication of dengue fever that affects the nervous system.